https://www.selleckchem.com/products/Cyt387.html
The analysis revealed a shorter surgery duration in the device group (23min, after controlling for procedure year and patient characteristics; statistically significant at p 0.001) and lower complication and readmission rates (p = 0.67 and p = 0.21, respectively) associated with the use of the device, leading to a statistically significant cost reduction of approximately 2060 US dollars (US$) (p 0.01). The study suggests that use of the device may lead to a cost reduction and shorter procedure without deteriorating the clinical
Gefällt mir
Kommentar
Teilen
